CIVILICA We Respect the Science
Publisher of Iranian Journals and Conference Proceedings
Paper
title

Association Micro-RNA 125 and Micro-RNA 152 Polymorphisms with Long Cancer Risk in Iranian Patients

Credit to Download: 0 | Page Numbers 1 | Abstract Views: 126
Year: 2017
Present: پوستري
COI code: IPMCMED02_011
Paper Language: English

How to Download This Paper

For Downloading the Fulltext of CIVILICA papers please visit the orginal Persian Section of website.

Authors Association Micro-RNA 125 and Micro-RNA 152 Polymorphisms with Long Cancer Risk in Iranian Patients

  Masoumeh Dehghan Manshadi - Medical Genetic Center, Endocrinology and Metabolism Research Institute (EMRI), Tehran University of Medical Sciences (TUMS), Tehran-Iran
  Vadieh Ghodsinezhad - Medical Genetic Center, Endocrinology and Metabolism Research Institute (EMRI), Tehran University of Medical Sciences (TUMS), Tehran-Iran
  Parvin Pishva - Medical Genetic Center, Endocrinology and Metabolism Research Institute (EMRI), Tehran University of Medical Sciences (TUMS), Tehran-Iran
  Arash Kadivari - Medical Genetic Center, Endocrinology and Metabolism Research Institute (EMRI), Tehran University of Medical Sciences (TUMS), Tehran-Iran

Abstract:

Lung cancer is the leading cause of cancer-related deaths worldwide, and about 80% of patients have non–small cell lung cancer (NSCLC).Both environmental and genetic factors contribute to the mortality of patients with NSCLC. Recent evidence indicates that small noncoding RNA molecules known as microRNAs (miRNAs) can function as tumor suppressors and oncogenes. The loss and gain of function of specific miRNAs were also thought to be key events in the genesis of diverse cancers .In lung cancer, miRNA expression profiles and specific miRNAs have been shown to be correlated with survival of lung adenocarcinomas. Single nucleotide polymorphisms (SNPs) or mutations occurring in the miRNA gene region may have effects on the function of miRNAs through altering miRNAs expression and/or maturation, consequently contributing to cancer susceptibility.In this case–control study, we genotyped two SNPs [rs12976445 (mir-152) and rs12940701 (mir-125a)] in Iranian patients with late-stage NSCLC and healthy control by PCR-RFLP methods. Our result provides evidence for the application of miRNA SNPs as predictive biomarkers in future personalized medicine for patients with NSCLC.

Keywords:

Perma Link

https://www.civilica.com/Paper-IPMCMED02-IPMCMED02_011.html
COI code: IPMCMED02_011

how to cite to this paper:

If you want to refer to this article in your research, you can easily use the following in the resources and references section:
Dehghan Manshadi, Masoumeh; Vadieh Ghodsinezhad; Parvin Pishva & Arash Kadivari, 2017, Association Micro-RNA 125 and Micro-RNA 152 Polymorphisms with Long Cancer Risk in Iranian Patients, 2nd International Personalized Medical Congress, تهران, دانشگاه علوم پزشكي بقيه الله(عج), https://www.civilica.com/Paper-IPMCMED02-IPMCMED02_011.htmlInside the text, wherever referred to or an achievement of this article is mentioned, after mentioning the article, inside the parental, the following specifications are written.
First Time: (Dehghan Manshadi, Masoumeh; Vadieh Ghodsinezhad; Parvin Pishva & Arash Kadivari, 2017)
Second and more: (Dehghan Manshadi; Ghodsinezhad; Pishva & Kadivari, 2017)
For a complete overview of how to citation please review the following CIVILICA Guide (Citation)

Scientometrics

The University/Research Center Information:
Type: Medical University
Paper No.: 6411
in University Ranking and Scientometrics the Iranian universities and research centers are evaluated based on scientific papers.

Research Info Management

Export Citation info of this paper to research management softwares

New Related Papers


The Above articles are recently indexed in the related subjects

Iran Scientific Advertisment Netword

Share this paper

WHAT IS COI?

COI is a national code dedicated to all Iranian Conference and Journal Papers. the COI of each paper can be verified online.